Research Articles

Characterization of Plasmodium falciparum isolated from the Amazon region of Brazil: evidence for quinine resistance

The prevalence and severity of drug-resistant malaria is emerging rapidly in the Amazon basin of Brazil. In support of clinical trials using the new antimalarial drug combination of atovaquone and proguanil, we performed in vitro drug sensitivities, molecular characterization of parasite populations using the circumsporozoite protein, merozoite surface antigen-1 (MSA-1), and MSA-2 markers, and an analysis of the Plasmodium falciparum multidrug resistance (pfmdr1) gene sequence and copy number in 26 isolates of P. falciparum obtained in a gold-mining endemic area in Peixoto de Azevedo, Mato Grosso State. All 26 isolates were found to be resistant to chloroquine (50% inhibitory concentration [IC50] = 100-620 nM) and sensitive to mefloquine (IC50 < 23 nM) and halofantrine (IC50 < 6 nM). The isolates also show reduced susceptibility to quinine (IC50 = 48-280 nM). Sequence analysis of the pfmdr1 gene revealed Asn, Phe, Cys, Asp, and Tyr in positions 86, 184, 1034, 1042, and 1246, respectively. These point mutations were similar to that previously described in other Brazilian isolates. Southern blot analysis revealed no amplification of the pfmdr1 gene. These results suggest that three different mechanisms for drug resistance exist for chloroquine, mefloquine, and quinine.

This article has been cited by other articles:

				S. Zakeri, M. Afsharpad, T. Kazemzadeh, K. Mehdizadeh, A. Shabani, and N. D. Djadid Association of pfcrt But Not pfmdr1 Alleles with Chloroquine Resistance in Iranian Isolates of Plasmodium falciparum Am J Trop Med Hyg, April 1, 2008; 78(4): 633 - 640. [Abstract] [Full Text] [PDF]

				E. Legrand, B. Volney, J.-B. Meynard, O. Mercereau-Puijalon, and P. Esterre In Vitro Monitoring of Plasmodium falciparum Drug Resistance in French Guiana: a Synopsis of Continuous Assessment from 1994 to 2005 Antimicrob. Agents Chemother., January 1, 2008; 52(1): 288 - 298. [Abstract] [Full Text] [PDF]

				D. MENARD, D. DJALLE, F. YAPOU, A. MANIRAKIZA, and A. TALARMIN FREQUENCY DISTRIBUTION OF ANTIMALARIAL DRUG-RESISTANT ALLELES AMONG ISOLATES OF PLASMODIUM FALCIPARUM IN BANGUI, CENTRAL AFRICAN REPUBLIC Am J Trop Med Hyg, February 1, 2006; 74(2): 205 - 210. [Abstract] [Full Text] [PDF]

				A. L. NELSON, A. PURFIELD, P. MCDANIEL, N. UTHAIMONGKOL, N. BUATHONG, S. SRIWICHAI, R. S. MILLER, C. WONGSRICHANALAI, and S. R. MESHNICK pfmdr1 GENOTYPING AND IN VIVO MEFLOQUINE RESISTANCE ON THE THAI-MYANMAR BORDER Am J Trop Med Hyg, May 1, 2005; 72(5): 586 - 592. [Abstract] [Full Text] [PDF]

				J. K. Baird Effectiveness of Antimalarial Drugs N. Engl. J. Med., April 14, 2005; 352(15): 1565 - 1577. [Full Text] [PDF]

				M. C. HUAMAN, N. RONCAL, S. NAKAZAWA, T. T. A. LONG, L. GERENA, C. GARCIA, L. SOLARI, A. J. MAGILL, and H. KANBARA POLYMORPHISM OF THE PLASMODIUM FALCIPARUM MULTIDRUG RESISTANCE AND CHLOROQUINE RESISTANCE TRANSPORTER GENES AND IN VITRO SUSCEPTIBILITY TO AMINOQUINOLINES IN ISOLATES FROM THE PERUVIAN AMAZON Am J Trop Med Hyg, May 1, 2004; 70(5): 461 - 466. [Abstract] [Full Text] [PDF]

				M. DEMAR and B. CARME PLASMODIUM FALCIPARUM IN VIVO RESISTANCE TO QUININE: DESCRIPTION OF TWO RIII RESPONSES IN FRENCH GUIANA Am J Trop Med Hyg, February 1, 2004; 70(2): 125 - 127. [Abstract] [Full Text] [PDF]

				D. P. Mawili-Mboumba, J. F. J. Kun, B. Lell, P. G. Kremsner, and F. Ntoumi Pfmdr1 Alleles and Response to Ultralow-Dose Mefloquine Treatment in Gabonese Patients Antimicrob. Agents Chemother., January 1, 2002; 46(1): 166 - 170. [Abstract] [Full Text] [PDF]

				R. N. Price, C. Cassar, A. Brockman, M. Duraisingh, M. van Vugt, N. J. White, F. Nosten, and S. Krishna The pfmdr1 Gene Is Associated with a Multidrug-Resistant Phenotype in Plasmodium falciparum from the Western Border of Thailand Antimicrob. Agents Chemother., December 1, 1999; 43(12): 2943 - 2949. [Abstract] [Full Text]